欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2013, Vol. 18 ›› Issue (6): 680-687.

• 药物治疗学 • 上一篇    下一篇

皖南地区人群131I治疗甲状腺功能亢进症的疗效及其影响因素

高家林1, 夏礼斌1, 陆美琴1, 张斌华1, 陈月平1, 张安素1, 赵咏莉1, 华强1, 何春玲1, 陶绍能2, 杨继文2, 邢凤军3, 程光华2   

  1. 1皖南医学院弋矶山医院内分泌科,
    2核医学科,芜湖 241001,安徽,
    3皖南医学院预防医学系2010级,芜湖 241002,安徽
  • 收稿日期:2013-04-08 修回日期:2013-05-09 发布日期:2013-06-19
  • 通讯作者: 张斌华,男,学士学位,主任医师,研究方向:内分泌疾病与治疗。Tel: 13505530321 E-mail: zhangbinhua_2012@126.com;程光华,男,学士学位,副教授,研究方向:核素显像与治疗。Tel: 13505536343 E-mail: cgh892@yahoo.com.cn
  • 作者简介:高家林,男,医学博士,主治医师,研究方向:内分泌疾病与治疗。Tel: 18355335266 E-mail: gaojialin_xr@126.com
  • 基金资助:
    弋矶山医院引进人才基金(YR201104)资助

Analysis of the curative effect of idine-131 therapy for Graves disease and its influencing factors in Southern Anhui patients

GAO Jia-lin1, XIA Li-bin1, LU Mei-qin1, ZHANG Bin-hua1, CHEN Yue-pin1, ZHANG An-su1, ZHAO Yong-li1, HUA Qiang1, HE Chun-lin1, TAO Shao-neng2, YANG Ji-wen2, XING Feng-jun3, CHEN Guang-hua2   

  1. 1Department of Endocrinology and Genetic Metabolism,
    2Department of Nuclear Medicine,Yijishan Hospital of Wannan Medical College, Wuhu 241001, Anhui, China,
    3Department of Preventive Medicine, Grade 2010, Wuhu 241002, Anhui, China
  • Received:2013-04-08 Revised:2013-05-09 Published:2013-06-19

摘要: 目的: 评价放射性131I 治疗Graves病患者的疗效,分析影响疗效的因素以及甲减发生情况。方法: 回顾性分析2011年1月至2012年3月在我院行131I 治疗并成功随访的398例Graves病患者。结果: 观察对象总治愈率达 46.7%,总有效率 86.7%;其中首次治愈率 48.6%,有效率为 87.3%; 治疗后1~3个月多数患者血FT3 、FT4 水平开始不同程度下降; 对治愈率分别进行单因素、多因素logistic回归分析表明甲状腺质量、24 h摄碘率、131I给药剂量、治疗次数及是否合并肝损是影响治愈的主要因素,甲状腺质量小者、24 h 摄碘率低者治愈率高,根据公式计算出给药剂量少者治愈率也高。对甲减发生的单因素分析表明,摄碘率低者甲减发生率较高(χ2=7.487,P=0.02367);而多因素回归分析表明性别、甲状腺质量、治疗次数是甲减发生的影响因素,女性、甲状腺质量小、首次治疗更易发生甲减(P均<0.05)。结论: 131I 治疗Graves病疗效较好,可作为治疗首选,但其疗效受多种因素影响, 需根据具体情况决定给药量。

关键词: Graves病, 131I, 治疗, 甲减

Abstract: AIM: To evaluate the therapeutic effect of 131I on patients with Graves disease, and analyze the influence factors of curative effect and the hypothyroidism occurrence.METHODS: The 398 patients had been retrospectively studied with definite diagnosis of Graves' disease within 2011 to 2012 after 131I treatment.RESULTS: Total curative rate was 46.7%, and the total effective rate was 86.7%. For the first time of treatment, the curative rate was 48.6%, and the effective rate was 87.3%. In most of the patients, the serum FT4 and FT3 were decreased in one to three months post 131I treatment. After statistical analyzing, 24 h 131I uptake rates, thyroid weight, dosage of 131I ,the number of treatment, were negative correlation with the curative rate, and with liver injury was also a impairing factors of therapy. Furthermore, in the numerous factors mentioned above, only 24 h 131I uptake rate has relationship with hypothyroidism occurrence in Single factor analysis way, which show as the lower iodine uptake rate with the higher incidence of hypothyroidism (χ2=7.487,P=0.02367);Multiple logistic regression analysis suggested that the gender, thyroid weight,the mumbers of treatment were significantly associated with the incidence of hypothyroidism.CONCLUSION: The curative effect of 131I therapy on Graves's disease was acceptable, and it can be used as the first choice of therapy for Graves's disease. However, individualized dosage should be used for the patients, because of the complex influence factors of therapeutic effects.

Key words: Graves disease, Iodine 131, Therapy, Hypothyroidism

中图分类号: